Pfizer (Australia) CISPLATIN 50mg/50mL injection vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer (australia) cisplatin 50mg/50ml injection vial

pfizer australia pty ltd - cisplatin, quantity: 50 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride; sodium hydroxide; mannitol - cisplatin injection may be used singularly or in combination with other chemotherapeutic agents in the treatment of: - metastatic nonseminomatous germ cell carcinoma; advanced stage, refractory ovarian carcinoma; advanced stage, refractory bladder carcinoma; refractory squamous cell carcinoma of the head and neck

DBL CISPLATIN 100mg/100mL Injection 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

dbl cisplatin 100mg/100ml injection

pfizer australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sodium chloride - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.

DBL CISPLATIN 50mg/50mL Injection 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

dbl cisplatin 50mg/50ml injection

pfizer australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; mannitol; water for injections - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.

CISPLATIN ACCORD cisplatin 25 mg/25 mL concentrated injection vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

cisplatin accord cisplatin 25 mg/25 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - cisplatin accord may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck

CISPLATIN ACCORD cisplatin 100 mg/100 mL concentrated injection vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

cisplatin accord cisplatin 100 mg/100 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium hydroxide; sodium chloride; water for injections; hydrochloric acid - cisplatin accord may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck

CISPLATIN ACCORD cisplatin 10 mg/10 mL concentrated injection vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

cisplatin accord cisplatin 10 mg/10 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - cisplatin accord may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck

CISPLATIN ACCORD cisplatin 50 mg/50 mL concentrated injection vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

cisplatin accord cisplatin 50 mg/50 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium chloride; sodium hydroxide; water for injections; hydrochloric acid - cisplatin accord may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck

Amitriptyline hydrochloride 10mg/5ml Oral Solution 아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

amitriptyline hydrochloride 10mg/5ml oral solution

syri pharma limited t/a thame laboratories - amitriptyline hydrochloride - oral solution - 10 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline

Amitriptyline hydrochloride 25mg/5ml Oral Solution 아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

amitriptyline hydrochloride 25mg/5ml oral solution

syri pharma limited t/a thame laboratories - amitriptyline hydrochloride - oral solution - 25 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline

Amitriptyline hydrochloride 50mg/5ml Oral Solution 아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

amitriptyline hydrochloride 50mg/5ml oral solution

syri pharma limited t/a thame laboratories - amitriptyline hydrochloride - oral solution - 50 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline